Screener
Eli Lilly LLY EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Eli Lilly’s reported figures.
The source filing: Eli Lilly’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 11:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000059478-26-000045
FAQ
- What is Eli Lilly's EBITDA?
- Eli Lilly (LLY) reported EBITDA of $9.36B in Q1 2026.
- How has Eli Lilly's EBITDA changed year-over-year?
- Eli Lilly's EBITDA increased by 138.8% year-over-year, from $3.92B to $9.36B.
- What is the long-term trend for Eli Lilly's EBITDA?
- Over 4 years (2021 to 2025), Eli Lilly's EBITDA has grown at a 37.7% compound annual growth rate (CAGR), from $7.7B to $27.73B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Eli Lilly's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude